Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.20
-0.57 (-1.51%)
Feb 11, 2026, 4:00 PM EST - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.66 billion as of February 12, 2026. Its market cap has increased by 473.71% in one year.
Market Cap
5.66B
Enterprise Value
5.33B
1-Year Change
473.71%
Ranking
Category
Stock Price
$37.20
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.66B, an increase of 4,453.90%. That is a compound annual growth rate of 97.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 5.66B | 4.73% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.58B |
| Rhythm Pharmaceuticals | 6.57B |
| Belite Bio | 6.57B |
| ImmunityBio | 6.44B |
| Caris Life Sciences | 6.07B |
| Mirum Pharmaceuticals | 5.98B |
| PTC Therapeutics | 5.69B |
| Immunovant | 5.28B |